Quest Diagnostics (NYSE:DGX) Given New $154.00 Price Target at Robert W. Baird
Quest Diagnostics (NYSE:DGX – Free Report) had its price target hoisted by Robert W. Baird from $153.00 to $154.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a neutral rating on the medical research company’s stock. Several other analysts have also weighed in on the company. Barclays upped […]
More Stories
Strike (STRK) Price Down 3.9% This Week
Strike (STRK) traded 7.7% higher against the US dollar during the one day period ending at 21:00 PM Eastern on...
Financial Survey: Obsidian Energy (OTCMKTS:OBELF) & Diversified Energy (NYSE:DEC)
Obsidian Energy (OTCMKTS:OBELF – Get Free Report) and Diversified Energy (NYSE:DEC – Get Free Report) are both small-cap oils/energy companies,...
Alchemy Pay (ACH) Reaches Self Reported Market Capitalization of $160.15 Million
Alchemy Pay (ACH) traded up 0.1% against the dollar during the 1 day period ending at 21:00 PM ET on...
PLATINCOIN (PLC) Hits 24 Hour Trading Volume of $2.32
PLATINCOIN (PLC) traded 0% lower against the US dollar during the one day period ending at 21:00 PM Eastern on...
WazirX (WRX) Hits 24 Hour Trading Volume of $424,952.22
WazirX (WRX) traded down 1.1% against the US dollar during the 24-hour period ending at 21:00 PM Eastern on October...
The Sandbox One Day Trading Volume Hits $32.25 Million (SAND)
The Sandbox (SAND) traded 1.4% higher against the U.S. dollar during the 24 hour period ending at 21:00 PM E.T....